Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02JDL
|
|||
| Drug Name |
Porfimer Sodium
|
|||
| Synonyms |
Photofrin
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25.Y] | Approved | [1] | |
| Company |
Concordia Laboratories Inc
|
|||
| ADReCS Drug ID | BADD_D01802 ; BADD_D01803 | |||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Low-density lipoprotein receptor (LDL-R) | Target Info | Modulator | [2] |
| KEGG Pathway | Endocytosis | |||
| Ovarian steroidogenesis | ||||
| Bile secretion | ||||
| Toxoplasmosis | ||||
| Hepatitis C | ||||
| NetPath Pathway | FSH Signaling Pathway | |||
| IL2 Signaling Pathway | ||||
| Reactome | LDL-mediated lipid transport | |||
| Chylomicron-mediated lipid transport | ||||
| Retinoid metabolism and transport | ||||
| WikiPathways | DNA Damage Response (only ATM dependent) | |||
| Statin Pathway | ||||
| Wnt Signaling Pathway | ||||
| Wnt Signaling Pathway and Pluripotency | ||||
| Visual phototransduction | ||||
| Lipid digestion, mobilization, and transport | ||||
| Oncostatin M Signaling Pathway | ||||
| SREBF and miR33 in cholesterol and lipid homeostasis | ||||
| SREBP signalling | ||||
| Folate Metabolism | ||||
| Vitamin B12 Metabolism | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.